Microfluidic devices take multiple shapes. The applications are diverse, with diagnostics, life sciences, drug delivery, and manufacturing being the main ones. Players performing well in this market are mainly the big companies, not generally expert in microfluidics but IVD systems. Almost 91% of the market (in value) is held by 20 players. COVID-19 has boosted the global microfluidics market from US$9.9 billion in 2019 to US$18.1 billion in 2021 (a growth of 45%). This dynamic can be explained by the widespread adoption of point-of-care (POC) solutions and next-generation sequencing (NGS) technologies.